p62 Compound as p62 ligand composition for preventing improving or treating proteinopathies comprising the same

摘要

The present invention relates to a novel p62 ligand compound, a stereoisomer, solvate, hydrate or prodrug thereof, and a pharmaceutical or food composition for the prevention or treatment of modified protein diseases comprising the same as an active ingredient, and the p62 ligand compound according to the present invention Silver can be usefully used as a pharmaceutical composition for preventing, ameliorating or treating various protein disorders by activating selective autophagy in cells to selectively remove proteins, organelles, and coagulations in the body.